A Study of Merestinib (LY2801653) in Healthy Participants

Inclusion Criteria: * Generally healthy sterile male and female participants * Body mass index (BMI) of 18.0 to 32.0 kilograms per square meter (kg/m²), inclusive * Are willing and able to eat the protocol specified high-fat breakfast Exclusion Criteria: * Have consumed grapefruits or grapefruit-containing products, Seville oranges or Seville orange juice, star fruit, star fruit juice, or star fruit-containing products, or commercial apple or orange juice within 14 days prior to first dosing * Regularly use known drugs of abuse and/or show positive findings on urinary drug screening * Have donated blood of more than 500 milliliters (mL) within the last month * Cannot stop taking over-the-counter (OTC) or prescription medications that alter gastric pH, at least 14 days prior to first dosing * Have previously completed or withdrawn from this study or any other study investigating merestinib, and have previously received the investigational product